Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

VDA Pharma

VDA Pharma?uq=UG6efJS6
2011 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$55K LATEST DEAL AMOUNT
Description

Developer of drugs for HIV treatment. The company develops a Viral Decay Acceleration molecule which serves as a treatment of HIV infection.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Primary Office
  • 108 Marlborough Street
  • Suite 4
  • Boston, MA 02116
  • United States

+1 (206) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore VDA Pharma’s full profile, request a free trial.

VDA Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 24-Sep-2015 $55K 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

VDA Pharma Board Members (3)

Name Representing Role Since Contact
Info
Donald Elmer Self Chairman 000 0000
John Essigmann Ph.D VDA Pharma Board Member 000 0000

1 Former Board Member

You’re viewing 2 of 3 board members. Get the full list »